Generated by GPT-5-mini| Ann McKee | |
|---|---|
| Name | Ann McKee |
| Nationality | American |
| Fields | Neuropathology, neuroscience |
| Workplaces | Boston University, Veterans Health Administration, Boston Medical Center, National Institutes of Health |
| Alma mater | College of the Holy Cross, Boston University School of Medicine |
| Known for | Research on chronic traumatic encephalopathy |
| Awards | Edgar A. Hyman Award, Dana Foundation grants |
Ann McKee is an American neuropathologist and neuroscientist noted for pioneering investigations into chronic traumatic encephalopathy (CTE), a neurodegenerative condition linked to repetitive head impacts. She holds leadership roles at Boston University and has collaborated with institutions including the Veterans Health Administration and the National Institutes of Health on brain bank initiatives, epidemiologic studies, and neuropathologic criteria development. McKee's work has influenced policy debates involving National Football League, National Collegiate Athletic Association, and International Olympic Committee stakeholders, and has intersected with research by groups at Mayo Clinic, Harvard University, and Columbia University.
McKee completed undergraduate studies at College of the Holy Cross and earned medical and postgraduate training at Boston University School of Medicine, where she later became faculty. Her postgraduate pathology and neuropathology training connected her to clinical centers such as Boston Medical Center and federal research programs run by the National Institutes of Health. During early career stages she engaged with neuropathologists from institutions like Johns Hopkins University and University of Pennsylvania, shaping her focus on neurodegenerative disease. Collaborations with senior investigators at Massachusetts General Hospital and exposure to forensic neuropathology influenced her interest in trauma-related brain disorders.
McKee serves as director of a neuropathology service and of a brain bank affiliated with Boston University and the Veterans Health Administration, combining clinical practice, translational research, and neuropathologic examination. Her laboratory applies immunohistochemistry, thioflavin staining, and tau protein assays informed by methods developed at Mayo Clinic and Columbia University to characterize tauopathies and other proteinopathies. McKee has contributed to neuropathologic staging systems and consensus criteria alongside experts from National Institute of Neurological Disorders and Stroke, University College London, and Imperial College London. She has co-authored studies integrating neuropathology with clinical data collected using instruments from World Health Organization and neuropsychological batteries common to research at University of California, San Francisco and Mount Sinai Health System.
Her translational agenda links brain donation programs with epidemiologic cohorts such as those coordinated by Framingham Heart Study–affiliated teams and population research centers at Harvard School of Public Health. McKee's group has collaborated with clinicians and scientists at Yale School of Medicine, University of Pittsburgh, and University of Toronto to examine biomarkers, neuroimaging correlates, and cerebrospinal fluid measures related to repetitive head trauma. Funding and partnerships have included agencies and foundations like the Department of Veterans Affairs, National Institute on Aging, and philanthropic organizations such as the Dana Foundation.
McKee is widely recognized for systematic neuropathologic descriptions of chronic traumatic encephalopathy, characterizing perivascular accumulation of hyperphosphorylated tau at the depths of cortical sulci and progressive stages of neurodegeneration. Her case series incorporated donated brains from former athletes affiliated with National Football League, National Hockey League, National Basketball Association, collegiate programs under National Collegiate Athletic Association, and participants in combat linked to United States Marine Corps and United States Army service. Reports from her group have been cited in policy discussions involving the National Football League Players Association, Centers for Disease Control and Prevention, and the Concussion Legacy Foundation.
McKee co-led neuropathologic consensus efforts with investigators from McLean Hospital, University of Cambridge, and University of Glasgow to propose diagnostic criteria distinguishing CTE from Alzheimer's disease and other tauopathies such as progressive supranuclear palsy and frontotemporal dementia. Her publications explored clinical phenotypes including mood, behavioral, and cognitive syndromes reported in cohorts studied by teams at Columbia University and Brown University. The methodology of her brain bank has been compared and contrasted with brain repositories at Mayo Clinic and international brain banks coordinated through networks like the International Brain Initiative.
Her work has provoked scientific debate with groups at King's College London and prompted replication studies and cohort investigations by consortia at University of Glasgow and University of Sydney. McKee has emphasized neuropathology while collaborating with epidemiologists, neurologists, and sports medicine researchers at Stanford University and University of Michigan to advance prospective research on head impact exposure and risk.
McKee has received awards and recognition from organizations including the Dana Foundation and honors tied to neuropathology and neuroscience societies. She has been an invited lecturer at conferences organized by the Society for Neuroscience, American Association of Neuropathologists, and the American Academy of Neurology. Her research has been profiled in media outlets and discussed in hearings involving legislators and agencies such as the United States Congress and the Department of Health and Human Services. Professional collaborations have led to joint acknowledgments with researchers from Harvard Medical School and Boston University School of Medicine.
McKee has advocated for brain donation programs, public awareness campaigns, and research infrastructure enhancements, working with advocacy organizations such as the Concussion Legacy Foundation and veterans' groups like Vietnam Veterans of America. She has engaged in interdisciplinary dialogues with ethicists and legal scholars at Georgetown University and Yale Law School on matters related to research consent and sports policy. Outside research, she has participated in symposia at institutions including Smithsonian Institution and public forums hosted by universities such as Tufts University.
Category:American neuropathologists Category:Boston University faculty